Vaccination Strategies for Emerging Disease Epidemics of Livestock

Veterinary Clinics of North America - Food Animal Practice

Volumn 26, Issue 1, 2010, Pages 173-183

  McVey, D Scott ^a   Shi, Jishu ^b  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

Foot and mouth disease; Immunization; Livestock immunization; Vaccination

Indexed keywords

VACCINE;

ANIMAL; ANIMAL DISEASE; COMMUNICABLE DISEASE; DOMESTIC ANIMAL; EPIDEMIC; IMMUNOLOGY; REVIEW; VACCINATION;

ANIMALS; ANIMALS, DOMESTIC; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; VACCINATION; VACCINES;

BOS;

EID: 73149111981     PISSN: 07490720     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvfa.2009.10.004     Document Type: Review

References (52)

1. Lombard M., Pastoret P.P., and Moulin A.M. A brief history of vaccines and vaccination. Rev Sci Tech 26 (2007) 29-48
2. Wehrle P.F. A reality in our time-certification of the global eradication of smallpox. J Infect dis 142 (1980) 636-638
3. Kretzschmar M., van den Hof S., Wallinga J., et al. Ring vaccination and smallpox control. Emerg Infect Dis 10 (2004) 832-841
4. McVey D.S., Galvin J.E., and Olson S.C. A review of the effectiveness of vaccine potency control testing. Int J Parasitol 33 (2003) 507-516
5. MacIntyre C.R., Seccull A., Lane J.M., et al. Development of a risk-priority score for category A bioterrorism agents as an aid for public health policy. Mil med 171 (2006) 589-594
6. Wildman B.K., Perrett T., Abutarbush S.M., et al. A comparison of 2 vaccination programs in feedlot calves at ultra-high risk of developing undifferentiated fever/bovine respiratory disease. La revue vétérinaire canadienne. Can Vet J 49 (2008) 463-472
7. Plummer P.J., Rohrbach B.W., Daugherty R.A., et al. Effect of intranasal vaccination against bovine enteric coronavirus on the occurrence of respiratory tract disease in a commercial backgrounding feedlot. J Am Vet Med Assoc 225 (2004) 726-731
8. Schat K.A., and Baranowski E. Animal vaccination and the evolution of viral pathogens. Rev Sci Tech 26 (2007) 327-338
9. Elsken L.A., Carr M.Y., Frana T.S., et al. Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America. Rev Sci Tech 26 (2007) 429-441
10. Keeling M.J., Woolhouse M.E., May R.M., et al. Modelling vaccination strategies against foot-and-mouth disease. Nature 421 (2003) 136-142
11. Kitching P., Hammond J., Jeggo M., et al. Global FMD control-is it an option?. Vaccine 25 (2007) 5660-5664
12. Woolhouse M., and Donaldson A. Managing foot-and-mouth. Nature 410 (2001) 515-516
13. Gloster J., Blackall R.M., Sellers R.F., et al. Forecasting the airborne spread of foot-and-mouth disease. Vet Rec 108 (1981) 370-374
14. Hugh-Jones M.E., and Wright P.B. Studies on the 1967-8 foot-and-mouth disease epidemic. The relation of weather to the spread of disease. J hyg (Lond) 68 (1970) 253-271
15. Donaldson A.I., and Doel T.R. Foot-and-mouth disease: the risk for Great Britain after 1992. Vet Rec 131 (1992) 114-120
16. Gibbens J.C., Sharpe C.E., Wilesmith J.W., et al. Descriptive epidemiology of the 2001 foot-and-mouth disease epidemic in Great Britain: the first five months. Vet Rec 149 (2001) 729-743
17. Ferguson N.M., Donnelly C.A., and Anderson R.M. The foot-and-mouth epidemic in Great Britain: pattern of spread and impact of interventions. Science 292 (2001) 1155-1160
18. Ferguson N.M., Donnelly C.A., and Anderson R.M. Transmission intensity and impact of control policies on the foot and mouth epidemic in Great Britain. Nature 413 (2001) 542-548
19. Woolhouse M., Chase-Topping M., Haydon D., et al. Epidemiology. Foot-and-mouth disease under control in the UK. Nature 411 (2001) 258-259
20. Howard S.C., and Donnelly C.A. The importance of immediate destruction in epidemics of foot and mouth disease. Res Vet Sci 69 (2000) 189-196
21. Howard S.C., and Donnelly C.A. Estimation of a time-varying force of infection and basic reproduction number with application to an outbreak of classical swine fever. J Epidemiol Biostat 5 (2000) 161-168
22. Doel T.R., Williams L., and Barnett P.V. Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 12 (1994) 592-600
23. Cox S.J., Barnett P.V., Dani P., et al. Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine 17 (1999) 1858-1868
24. Sanz-Parra A., Vázquez B., Sobrino F., et al. Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. J Gen Virol 80 (1999) 671-679
25. Salt J.S., Barnett P.V., Dani P., et al. Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine 16 (1998) 746-754
26. Gay C. Presented at The 5th International Veterinary Vaccines and Diagnostic Conference. Madison, June 19-23, 2009.
27. Doel T.R. FMD vaccines. Virus Res 91 (2003) 81-99
28. Parida S. Vaccination against foot-and-mouth disease virus: strategies and effectiveness. Expert Rev Vaccines 8 (2009) 347-365
29. De Clercq K., Goris N., Barnett P.V., et al. FMD vaccines: reflections on quality aspects for applicability in European disease control policy. Transbound Emerg Dis 55 (2008) 46-56
30. World Organisation for Animal Health (OIE) Foot and mouth disease. In: Manual of diagnostic tests and vacanies for terrestrial animals 2008: mammals, birds, and bees. Vol. 1. 6th edition. Paris: Office International des Epizooties; 2008.
31. Goris N., Willems T., Diev V.I., et al. Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative. Vaccine 26 (2008) 3870-3879
32. Parida S., Fleming L., Oh Y., et al. Reduction of foot-and-mouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge. Vaccine 25 (2007) 7806-7817
33. Parida S., Fleming L., Oh Y., et al. Emergency vaccination of sheep against foot-and-mouth disease: significance and detection of subsequent sub-clinical infection. Vaccine 26 (2008) 3469-3479
34. Cox S.J., Parida S., Voyce C., et al. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge. Vaccine 25 (2007) 7687-7695
35. Salt J.S. The carrier state in foot and mouth disease-an immunological review. Br Vet J 149 (1993) 207-223
36. Salt J.S., Mulcahy G., and Kitching R.P. Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of "carrier" and "non-carrier" cattle. Epidemiol infect 117 (1996) 349-360
37. Sobrino F., Sáiz M., Jiménez-Clavero M.A., et al. Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res 32 1 (2001) 1-30
38. Blanco E., Garcia-Briones M., Sanz-Parra A., et al. Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol 75 7 (2001) 3164-3174
39. Collen T., Baron J., Childerstone A., et al. Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen. Virus Res 56 (1998) 125-133
40. Childerstone A.J., Cedillo-Baron L., Foster-Cuevas M., et al. Demonstration of bovine CD8+ T-cell responses to foot-and-mouth disease virus. J Gen Virol 80 (1999) 663-669
41. Foster M., Cook A., Cedillo L., et al. Serological and cellular immune responses to non-structural proteins in animals infected with FMDV. Vet Q 20 Suppl 2 (1998) S28-S30
42. García-Briones M.M., Russell G.C., Oliver R.A., et al. Association of bovine DRB3 alleles with immune response to FMDV peptides and protection against viral challenge. Vaccine 19 (2000) 1167-1171
43. Zhang Z.D., Hutching G., Kitching P., et al. The effects of gamma interferon on replication of foot-and-mouth disease virus in persistently infected bovine cells. Arch Virol 147 (2002) 2157-2167
44. van Lierop M.J., van Maanen K., Meloen R.H., et al. Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. Immunology 75 (1992) 406-413
45. Cox S.J., and Barnett P.V. Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review. Vet Res 40 (2009) 13
46. Dong X.N., and Chen Y.H. Marker vaccine strategies and candidate CSFV marker vaccines. Vaccine 25 (2007) 205-230
47. Mongoh M.N., Dyer N.W., Stoltenow C.L., et al. Risk factors associated with anthrax outbreak in animals in North Dakota, 2005: a retrospective case-control study. Public Health Rep 123 (2008) 352-359
48. Kaufmann A.F., Fox M.D., and Kolb R.C. Anthrax in Louisiana, 1971: an evaluation of the Sterne strain anthrax vaccine. J Am Vet Med Assoc 163 (1973) 442-445
49. Fox M.D., Kaufmann A.F., Zendel S.A., et al. Anthrax in Louisiana, 1971: epizootiologic study. J Am Vet Med Assoc 163 (1973) 446-451
50. Dragon D.C., and Rennie R.P. The ecology of anthrax spores: tough but not invincible. La revue vétérinaire canadienne. Can Vet J 36 (1995) 295-301
51. Dragon D.C., Bader D.E., Mitchell J., et al. Natural dissemination of Bacillus anthracis spores in northern Canada. Appl Environ Microbiol 71 (2005) 1610-1615
52. Turner A.J., Galvin J.W., Rubira R.J., et al. Experiences with vaccination and epidemiological investigations on an anthrax outbreak in Australia in 1997. J Appl Microbiol 87 (1999) 294-297